Neoplasms

All Conditions

Skin and Connective Tissue Diseases

Eye Diseases

Rare Diseases

Carcinoma

Melanoma

Neuroendocrine Tumors

Neuroectodermal Tumors

Neuroectodermal Tumors, Primitive

Neoplasms, Germ Cell and Embryonal

Neoplasms by Histologic Type

Neoplasms, Nerve Tissue

Nevus, Pigmented

Nevus

Nevi and Melanomas

Skin Neoplasms

Skin Diseases

Conjunctival Melanoma

Neuroendocrine Tumor

Neuroepithelioma

Intraoperative lymphatic mapping, then biopsy/removal of the conjunctiva/eyelid tumor.

Sentinel Lymph Node Mapping and Biopsy

Bita Esmaeli, MD

The goal of this clinical research study is to find the sentinel lymph node (SLN) (s) and biopsy it (them) to see if the patient has small or low volume metastatic disease that would otherwise have been missed.

You have had your conjunctival or eyelid tumor surgically removed or it is scheduled to have it removed. You will have lymphatic mapping before the tumor is removed. Lymphatic mapping is when a small volume of Tc99m-Sulfur colloid is injected by an ophthalmologist after which some radiologic images are taken.

If you are able to become pregnant, blood (about 2 teaspoons) will be drawn for a pregnancy test, within 7 days before the biopsy. To take part in this study, you must not be pregnant.

You will then go to the operating room and have intraoperative SLN mapping and biopsy. If the SLN is positive on permanent section, you will go on to have complete lymph node dissection, which involves removal of all the lymph nodes around the positive SLN. Then the disease will be restaged and you may require further treatment after consultation with their oncologist.

Your medical record will be reviewed, and information from your medical record will be recorded and reviewed to help researchers better identify those patients who have microscopic lymph node disease. The information collected from your medical records will include information about your sex, age, what type of cancer that you have, as well as the size of the cancer and its location.

Researchers hope to identify those patients who have microscopic lymph node disease before it becomes clinically obvious. With this technique, researchers could potentially identify occult metastatic disease which would otherwise go unnoticed until it was too advanced. Patients in this study will have to see the ophthalmologist every three months and have the usual metastatic workup, which is routine for conjunctival/eyelid melanoma.

Length of Study:

Your active participation on this study will be over once the biopsy is over. You will continue to be observed on study for 5 years after the biopsy.

Long-Term Follow-Up:

Every 3 months for the first year after the biopsy, and every 6 months after that until 5 years after the biopsy, you will have an eye exam to check the status of the disease.

Every 6 months for the first year after the biopsy, blood (less than 1 teaspoon) will be drawn for liver function tests. You will also have a chest x-ray. You will then have these tests 1 time each year for 5 years after the biopsy.

You will have a head and neck CT or MRI every 6 months for the first year after the biopsy to make sure the disease has not come back. The head and neck CT or MRI will be repeated 1 time each year for 5 years after the biopsy.

This is an investigational study. A total of 38 patients will take part in this study. All will be enrolled at MD Anderson Cancer Center.

Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma

Sentinel Lymph Node Localization and Biopsy for Conjunctival and Eyelid Melanoma

The frequency of lymphatic drainage basins for bulbar versus palpebral conjunctiva and for nasal and the temporal quadrants estimated with 95% confidence intervals. The rate of identification of SLN evaluated with a confidence interval. The probability of positive SLN in primary conjunctival and eyelid melanoma estimated.

M.D. Anderson Cancer Center

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Endometrial Neoplasms

Uterine Neoplasms

Genital Neoplasms, Female

Urogenital Neoplasms

Uterine Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

woman who had sentinel lymph node mapping and biopsy

woman who underwent traditional pelvic lymphadenectomy without sentinel lymph node mapping

Sentinel lymph node mapping with indocyanine green dye followed by biopsy if positive

Sentinel lymph node mapping and biopsy

Lymphadenectomy

To compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage endometrial cancer.

This retrospective study aims to compare sentinel lymph nodes biopsy versus comprehensive lymphadenectomy in patients with early stage endometrial cancer by reviewing the medical records.

Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer

Sentinel Lymph Node Biopsy Versus Pelvic Lymphadenectomy in Early Stage Endometrial Cancer

The length of time from the day of operation till recurrence or last follow up

The length of time from the day of operation till death (of any cause) or last follow up

asymptomatic lymphocele, lymphedema, infected lymphocele

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma	NCT00386906	Eye Disease Melanoma	Sentinel Lymph ...	18 Years -	M.D. Anderson Cancer Center
Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer	NCT05048173	Early Stage End... Sentinel Lymph ... Lymphadenectomy	Sentinel lymph ... Lymphadenectomy	20 Years -	Far Eastern Memorial Hospital
Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma	NCT00386906	Eye Disease Melanoma	Sentinel Lymph ...	18 Years -	M.D. Anderson Cancer Center

Spots Global Cancer Trial Database for sentinel lymph node mapping and biopsy